{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:15Z","timestamp":1786119555355,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/iae.0b013e3181dde70b","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T07:46:28Z","timestamp":1281599188000},"page":"1734-1738","source":"Crossref","is-referenced-by-count":4,"title":["INTRAOCULAR AND SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN ACUTE RETINAL NECROSIS AND OCULAR TOXOPLASMOSIS"],"prefix":"10.1097","volume":"30","author":[{"given":"Karin","family":"Wiertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenneke De","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ger","family":"Rijkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda De","family":"Groot-Mijnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Los","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniki","family":"Rothova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20210130","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ophtha.2006.08.037","article-title":"Acute retinal necrosis features, management, and outcomes.","volume":"114","author":"Lau","year":"2007","journal-title":"Ophthalmology"},{"key":"R2-25-20210130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-200502000-00001","article-title":"The role of vascular endothelial growth factor in ocular health and disease.","volume":"25","author":"Adamis","year":"2005","journal-title":"Retina"},{"key":"R3-25-20210130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jneuroim.2004.11.013","article-title":"Antibody neutralization of vascular endothelial growth factor (VEGF) fails to attenuate vascular permeability and brain edema in experimental pneumococcal meningitis.","volume":"160","author":"van der Flier","year":"2005","journal-title":"J Neuroimmunol"},{"key":"R4-25-20210130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2249.2003.02101.x","article-title":"High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies.","volume":"132","author":"Drouart","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"R5-25-20210130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10875-007-9083-1","article-title":"Vascular endothelial growth factor (VEGF) in autoimmune diseases.","volume":"27","author":"Carvalho","year":"2007","journal-title":"J Clin Immunol"},{"key":"R6-25-20210130","doi-asserted-by":"crossref","first-page":"10249","DOI":"10.1128\/JVI.00763-07","article-title":"Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor.","volume":"81","author":"Nasimuzzaman","year":"2007","journal-title":"J Virol"},{"key":"R7-25-20210130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000086594","article-title":"Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy.","volume":"37","author":"Sydorova","year":"2005","journal-title":"Ophthalmic Res"},{"key":"R8-25-20210130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/09629350310001619726","article-title":"Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.","volume":"12","author":"Robak","year":"2003","journal-title":"Mediators Inflamm"},{"key":"R9-25-20210130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2133.2006.07536.x","article-title":"The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behcet disease.","volume":"156","author":"Shaker","year":"2007","journal-title":"Br J Dermatol"},{"key":"R10-25-20210130","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0002-9394(01)01103-5","article-title":"Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema.","volume":"132","author":"Fine","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R11-25-20210130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.diabres.2007.10.018","article-title":"Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.","volume":"79","author":"Kakehashi","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"R12-25-20210130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ajo.2004.11.064","article-title":"Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration.","volume":"139","author":"Hera","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R14-25-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2008.09.037","article-title":"Association of vitreous inflammatory factors with diabetic macular edema.","volume":"116","author":"Funatsu","year":"2009","journal-title":"Ophthalmology"},{"key":"R15-25-20210130","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/eye.2008.388","article-title":"Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab.","volume":"23","author":"Weiss","year":"2009","journal-title":"Eye"},{"key":"R16-25-20210130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000102935","article-title":"Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema.","volume":"39","author":"Jonas","year":"2007","journal-title":"Ophthalmic Res"},{"key":"R17-25-20210130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-2003-41362","article-title":"Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor. a pilot study.","volume":"35","author":"Boehm","year":"2003","journal-title":"Horm Metab Res"},{"key":"R18-25-20210130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/IAE.0b013e318195cb15","article-title":"Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment.","volume":"29","author":"Roh","year":"2009","journal-title":"Retina"},{"key":"R19-25-20210130","first-page":"1061","article-title":"Vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGFbeta), and interleukin-6 (IL-6) in experimental herpesvirus retinopathy: association with inflammation and viral infection.","volume":"16","author":"Vinores","year":"2001","journal-title":"Histol Histopathol"},{"key":"R20-25-20210130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/ICU.0b013e3282fb7c45","article-title":"Update on treatments for diabetic macular edema.","volume":"19","author":"Fraser-Bell","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"key":"R21-25-20210130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/ICU.0b013e32832d25b3","article-title":"Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.","volume":"20","author":"Ciulla","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"R22-25-20210130","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/IAE.0b013e3181aa8dfe","article-title":"Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion.","volume":"29","author":"Gregori","year":"2009","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0b013e3181dde70b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:35:03Z","timestamp":1786041303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201011000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181dde70b","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}